Jiafu Ji
Peking University Cancer Hospital, Beijing, Beijing 100142, China · Peking University Cancer Hospital & Institute · Cancer Hospital Affiliated to Peking University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jiafu Ji as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:19 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07700979 · Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ AdenocarcinomaAkeso · recruiting · Gastric / Gastroesophageal Junction Adenocarcinoma · principal investigator
- N/ANCT07547787 · A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)Akeso · recruiting · Locally Advanced Unresectable or Metastatic Gastric Cancer · principal investigator
- Ph2NCT07178340 · Perioperative Therapy for HER2-negative Hepatoid Adenocarcinoma of StomachPeking University Cancer Hospital & Institute · recruiting · Hepatoid Adenocarcinoma of Stomach · principal investigator
- Ph2NCT06992362 · Perioperative Treatment of Hepatoid Adenocarcinoma of StomachPeking University Cancer Hospital & Institute · recruiting · Hepatoid Adenocarcinoma of Stomach · principal investigator
- Ph3NCT05008783 · A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ AdenocarcinomaAkeso · completed · Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma · principal investigator
- Ph1NCT04764084 · Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid TumorsPeking University Cancer Hospital & Institute · unknown · HER2-negative Breast Cancer, Gastric Adenocarcinoma, Cholangiocarcinoma · principal investigator
- Ph2NCT04556253 · Perioperative Cadonilimab (AK104) in Locally Advanced MSI-H/dMMR Gastric or Gastroesophageal Junction and Colorectal AdenocarcinomaPeking University · active not recruiting · MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer · principal investigator
- N/ANCT04047953 · Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric AdenocarcinomaPeking University Cancer Hospital & Institute · recruiting · Gastric Adenocarcinoma · principal investigator
- Ph2/Ph3NCT03691454 · Compare Neoadjuvant DOS Combined With Toripalimab Versus SOX Combined With Toripalimab in Locally Advanced Gastric AdenocarcinomaPeking University · active not recruiting · Gastric Adenocarcinoma · principal investigator
- N/ANCT03493880 · The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative TreatmentsPeking University · unknown · Gastric Cancer, Neoadjuvant Chemotherapy, Neoadjuvant Chemoradiotherapy · principal investigator
- N/ANCT03425058 · Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric CancerPeking University Cancer Hospital & Institute · completed · Gastric Cancer · study chair
- N/ANCT03413514 · Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision MakingPeking University · unknown · Gastric Cancer · principal investigator
- Ph1NCT03393416 · A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild TumorHRYZ Biotech Co. · unknown · Advanced Gastric Cancer · principal investigator
- N/ANCT02969122 · Treatment Strategy for Stage IV Gastric Cancer with Positive Peritoneal Cytology As the Only Non-curable FactorPeking University · terminated · Stomach Neoplasm · principal investigator
- Ph3NCT02867839 · Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric CancerPeking University Cancer Hospital & Institute · terminated · Gastric Cancer · study chair
- Ph2/Ph3NCT02193594 · Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric AdenocarcinomaPeking University · unknown · Gastroesophageal Junction Adenocarcinoma · principal investigator
- N/ANCT02179463 · Compare Different Response Evaluations to Neoadjuvant Chemotherapy for Gastric CancerPeking University · unknown · Gastric Cancer · principal investigator
- N/ANCT02172690 · Laparoscopic Staging for Locally Advanced Gastric Cancer in Chinese PatientsPeking University · completed · Gastric Cancer, Peritoneal Metastases · principal investigator
- Ph2NCT02163291 · Study on Neoadjuvant Chemotherapy for Advanced Gastric CancerPeking University · unknown · Advanced Gastric Carcinoma · principal investigator
- Ph2NCT01471132 · Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum MetastasisPeking University · unknown · Gastric Cancer, Metastases to Perineum · study chair
- Ph2NCT01167049 · Xeloda Plus Paclitaxel in Gastric Cancer With Liver MetastasisPeking University Cancer Hospital & Institute · unknown · Gastric Cancer · principal investigator
- Ph2NCT00591045 · Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric CancerPeking University · unknown · Stomach Neoplasms, Gastric Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:19 UTC. The ranking covers the 200 most relevant of 255 PubMed records, and a shared surname and initials can bring in a namesake. All 255 on PubMed
- 2,002 citationsRCR 73.0
- 1,455 citationsRCR 45.2
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.Lancet Oncol · 2014868 citationsRCR 26.4
- 609 citationsRCR 30.9
- 581 citationsRCR 30.1
- 384 citationsRCR 22.8
- 316 citationsRCR 19.8
- 314 citationsRCR 15.1
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.Cancer Immunol Immunother · 2013304 citationsRCR 8.4
- Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors.J Clin Oncol · 2015287 citationsRCR 7.6